CG Oncology, Inc. · NASDAQ:CGON

CG Oncology, Inc. financial statements

CG Oncology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023
Revenue4.04M1.14M204.0K
Research and development116.6M82.1M45.8M
Operating income-190.8M-114.7M-55.4M
Depreciation and amortization1.45M32.0K17.0K
EBITDA-189.3M-114.6M-55.4M
Income tax-270.0K1.00K1.00K
Net income-161.0M-88.0M-48.6M
Earnings per share, basic-2.08-1.41-15.65
Earnings per share, diluted-2.08-1.41-15.65

Balance sheet

LineFY2025FY2024FY2023
Cash and equivalents32.5M257.1M8.27M
Short-term investments709.7M484.9M179.4M
Receivables688.0K0
Inventory1.56M0
Current assets759.5M754.2M194.1M
Property, plant and equipment15.6M272.0K69.0K
Goodwill10.3M0
Total assets791.6M754.8M199.3M
Accounts payable5.71M6.52M3.24M
Current liabilities30.8M21.4M14.3M
Long-term debt3.00M0
Total debt3.00M0
Total liabilities39.0M21.4M14.5M
Shareholders' equity752.6M733.4M-123.1M
Shares outstanding80.7M76.2M5.22M

Cash flow

LineFY2025FY2024FY2023
Cash from operations-132.3M-78.7M-45.7M
Capital spending-134.0K-234.0K
Free cash flow-132.5M-78.9M
Cash from investing-245.8M-300.8M-121.2M
Cash from financing153.6M628.3M87.0M
Change in cash-224.6M248.8M-79.9M